Steven M. Leventer

500 total citations
17 papers, 406 citations indexed

About

Steven M. Leventer is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Steven M. Leventer has authored 17 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Cellular and Molecular Neuroscience and 6 papers in Pharmacology. Recurrent topics in Steven M. Leventer's work include Receptor Mechanisms and Signaling (7 papers), Neuroscience and Neuropharmacology Research (6 papers) and Nicotinic Acetylcholine Receptors Study (5 papers). Steven M. Leventer is often cited by papers focused on Receptor Mechanisms and Signaling (7 papers), Neuroscience and Neuropharmacology Research (6 papers) and Nicotinic Acetylcholine Receptors Study (5 papers). Steven M. Leventer collaborates with scholars based in United States, Belgium and Canada. Steven M. Leventer's co-authors include Israel Hanin, Ernst Wülfert, Michael Clancy, Richard L. Rudolph, Arifulla Khan, Richard Entsuah, G. Virginia Upton, Kenneth M. Johnson, Christine L. Frissora and Allen W. Mangel and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, The American Journal of Gastroenterology and Life Sciences.

In The Last Decade

Steven M. Leventer

17 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven M. Leventer United States 10 196 176 149 71 66 17 406
Richard C. Ursillo United States 12 123 0.6× 275 1.6× 239 1.6× 26 0.4× 15 0.2× 15 554
Richard T Owen United Kingdom 12 79 0.4× 92 0.5× 69 0.5× 54 0.8× 9 0.1× 36 364
Love Linnér Sweden 9 58 0.3× 191 1.1× 97 0.7× 61 0.9× 22 0.3× 14 350
Linda Ferrington United Kingdom 12 115 0.6× 188 1.1× 130 0.9× 53 0.7× 6 0.1× 22 464
Kazuyuki Hidaka Japan 12 91 0.5× 365 2.1× 412 2.8× 47 0.7× 10 0.2× 22 713
Taiichiro Imanishi Japan 11 129 0.7× 208 1.2× 168 1.1× 68 1.0× 4 0.1× 17 422
R. J. NAYLOR United Kingdom 10 54 0.3× 164 0.9× 102 0.7× 52 0.7× 9 0.1× 21 422
Judit Laszy Hungary 10 69 0.4× 275 1.6× 184 1.2× 74 1.0× 8 0.1× 18 528
Kim L. Matthews United Kingdom 9 53 0.3× 136 0.8× 196 1.3× 41 0.6× 44 0.7× 14 453
D.R. Thomas United Kingdom 8 200 1.0× 196 1.1× 109 0.7× 32 0.5× 4 0.1× 11 542

Countries citing papers authored by Steven M. Leventer

Since Specialization
Citations

This map shows the geographic impact of Steven M. Leventer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven M. Leventer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven M. Leventer more than expected).

Fields of papers citing papers by Steven M. Leventer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven M. Leventer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven M. Leventer. The network helps show where Steven M. Leventer may publish in the future.

Co-authorship network of co-authors of Steven M. Leventer

This figure shows the co-authorship network connecting the top 25 collaborators of Steven M. Leventer. A scholar is included among the top collaborators of Steven M. Leventer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven M. Leventer. Steven M. Leventer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Brisard, Claudine, Beth Safirstein, Kevin Booth, et al.. (2010). P1‐457: Safety, tolerability, and preliminary efficacy of SAM‐531, a 5HT‐6 antagonist, in subjects with mild‐to‐moderate Alzheimer's disease: Results from a phase 2a study. Alzheimer s & Dementia. 6(4S_Part_10). 6 indexed citations
2.
Leventer, Steven M., et al.. (2007). Clinical trial: dextofisopam in the treatment of patients with diarrhoea‐predominant or alternating irritable bowel syndrome. Alimentary Pharmacology & Therapeutics. 27(2). 197–206. 61 indexed citations
3.
Leventer, Steven M., et al.. (2004). THE POTENTIAL OF DEXTOFISOPAM FOR TREATMENT OF IRRITABLE BOWEL SYNDROME AND INFLAMMATORY BOWEL DISEASE. The American Journal of Gastroenterology. 99. S279–S279. 14 indexed citations
4.
Klein, Donald F., Michael E. Thase, Jean Endicott, et al.. (2002). Improving Clinical Trials. Archives of General Psychiatry. 59(3). 272–272. 21 indexed citations
5.
Khan, Arifulla, G. Virginia Upton, Richard L. Rudolph, Richard Entsuah, & Steven M. Leventer. (1998). The Use of Venlafaxine in the Treatment of Major Depression and Major Depression Associated With Anxiety. Journal of Clinical Psychopharmacology. 18(1). 19–25. 66 indexed citations
6.
Boast, Carl A., Steven M. Leventer, Annmarie L. Sabb, et al.. (1991). Biochemical and behavioral characterization of a novel cholinergic agonist, SR 95639. Pharmacology Biochemistry and Behavior. 39(2). 287–292. 2 indexed citations
7.
Abou‐Gharbia, Magid, et al.. (1990). Preclinical profile of Wy‐49,051: A new H1‐antagonist. Drug Development Research. 21(1). 63–78. 2 indexed citations
8.
Hörtnagl, Heide, et al.. (1988). Role of the aziridinium moiety in the in vivo cholinotoxicity of ethylcholine aziridinium ion (AF64A). Journal of Neuroscience Methods. 23(2). 107–113. 11 indexed citations
9.
Leventer, Steven M., Ernst Wülfert, & Israel Hanin. (1987). Time course of ethylcholine aziridinium ion (AF64A)-induced cholinotoxicity in vivo. Neuropharmacology. 26(4). 361–365. 73 indexed citations
10.
Stewart, Dwight J., Steven M. Leventer, Israel Hanin, & C.H. Vanderwolf. (1987). Hippocampal electrical activity in relation to behavior following ethylcholine aziridinium ion (AF64A) treatment. Pharmacology Biochemistry and Behavior. 26(2). 357–364. 5 indexed citations
11.
Rowell, P., Steven M. Leventer, & Mary J. Clark. (1986). The Effect of Cigarette Smoking during Pregnancy on the Cholinergic System in Isolated Term Human Placental Tissue1. Biology of Reproduction. 34(2). 344–348. 1 indexed citations
12.
13.
Vickroy, Thomas W., Melanie Watson, Steven M. Leventer, et al.. (1985). Regional differences in ethylcholine mustard aziridinium ion (AF64A)-induced deficits in presynaptic cholinergic markers for the rat central nervous system.. Journal of Pharmacology and Experimental Therapeutics. 235(3). 577–582. 37 indexed citations
14.
Leventer, Steven M. & Kenneth M. Johnson. (1984). Phencyclidine-induced inhibition of striatal acetylcholine release: Comparisons with mu, kappa, and sigma opiate agonists. Life Sciences. 34(8). 793–801. 11 indexed citations
15.
Leventer, Steven M. & P. Rowell. (1984). Investigation of the rate-limiting step in the synthesis of acetylcholine by the human placenta. Placenta. 5(3). 261–270. 8 indexed citations
16.
Leventer, Steven M. & Kenneth M. Johnson. (1983). Effects of phencyclidine on the release of radioactivity from rat striatal slices labeled with [3H]choline.. Journal of Pharmacology and Experimental Therapeutics. 225(2). 332–336. 13 indexed citations
17.
Leventer, Steven M., P. Rowell, & Mary J. Clark. (1982). The effect of choline acetyltransferase inhibition on acetylcholine synthesis and release in term human placenta.. Journal of Pharmacology and Experimental Therapeutics. 222(2). 301–305. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard C. Ursillo Breakdown of academic impact, for papers by Richard T Owen Breakdown of academic impact, for papers by Love Linnér Breakdown of academic impact, for papers by Linda Ferrington Breakdown of academic impact, for papers by Kazuyuki Hidaka Breakdown of academic impact, for papers by Taiichiro Imanishi Breakdown of academic impact, for papers by R. J. NAYLOR Breakdown of academic impact, for papers by Judit Laszy Breakdown of academic impact, for papers by Kim L. Matthews Breakdown of academic impact, for papers by D.R. Thomas
Rankless by CCL
2026